Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19

C Rodríguez, N Luque, I Blanco… - American journal of …, 2021 - atsjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new strain of a
Coronaviridae virus that presents 79% genetic similarity to the severe acute respiratory …

Pulmonary vascular system: A vulnerable target for COVID‐19

J Ai, W Hong, M Wu, X Wei - MedComm, 2021 - Wiley Online Library
The number of coronavirus disease 2019 (COVID‐19) cases has been increasing
significantly, and the disease has evolved into a global pandemic, posing an unprecedented …

Between inflammation and thrombosis: endothelial cells in COVID-19

A Birnhuber, E Fliesser, G Gorkiewicz… - European …, 2021 - Eur Respiratory Soc
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current
coronavirus disease (COVID-19) pandemic [1]. Over recent months, a plethora of novel …

Novel insights on the pulmonary vascular consequences of COVID-19

F Potus, V Mai, M Lebret, S Malenfant… - … of Physiology-Lung …, 2020 - journals.physiology.org
In the last few months, the number of cases of a new coronavirus-related disease (COVID-
19) rose exponentially, reaching the status of a pandemic. Interestingly, early imaging …

[HTML][HTML] Endotheliopathy in acute COVID-19 and long COVID

AG Vassiliou, CS Vrettou, C Keskinidou… - International Journal of …, 2023 - mdpi.com
The pulmonary endothelium is a highly regulated organ that performs a wide range of
functions under physiological and pathological conditions. Since endothelial dysfunction …

[HTML][HTML] COVID-19 and pulmonary angiogenesis: the possible role of hypoxia and hyperinflammation in the overexpression of proteins involved in alveolar vascular …

AFRS Miggiolaro, FPG da Silva, DB Wiedmer… - Viruses, 2023 - mdpi.com
COVID-19 has been considered a vascular disease, and inflammation, intravascular
coagulation, and consequent thrombosis may be associated with endothelial dysfunction …

[HTML][HTML] Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19

WO Osburn, K Smith, L Yanek, N Amat-Alcaron… - PloS one, 2022 - journals.plos.org
Severe coronavirus disease-19 (COVID-19) is characterized by vascular inflammation and
thrombosis. We and others have proposed that the inflammatory response to coronavirus …

Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID‐19—Mechanisms and Therapeutic Targets

A Fodor, B Tiperciuc, C Login… - Oxidative medicine …, 2021 - Wiley Online Library
The outbreak of the COVID‐19 pandemic represents an ongoing healthcare emergency
responsible for more than 3.4 million deaths worldwide. COVID‐19 is the disease caused by …

[HTML][HTML] Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19

T Maruhashi, Y Higashi - International Journal of Molecular Sciences, 2021 - mdpi.com
The outbreak of coronavirus disease 2019 (COVID-19) caused by the betacoronavirus
SARS-CoV-2 is now a worldwide challenge for healthcare systems. Although the leading …

[HTML][HTML] Mechanisms of COVID-19 associated pulmonary thrombosis: a narrative review

CM Niculae, A Hristea, R Moroti - Biomedicines, 2023 - mdpi.com
COVID-19, the infectious disease caused by severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2), is frequently associated with pulmonary thrombotic events, especially in …